z-logo
Premium
Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes
Author(s) -
Germack Renée,
Dickenson John M
Publication year - 2004
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0705614
Subject(s) - adenosine , cgs 21680 , adenosine a3 receptor , adenosine receptor , adenosine a2b receptor , adenosine kinase , pertussis toxin , adenosine a1 receptor , adenylyl cyclase , protein kinase a , agonist , purinergic signalling , phosphorylation , medicine , protein kinase c , endocrinology , chemistry , signal transduction , biology , receptor , adenosine deaminase , stimulation , biochemistry , g protein
Adenosine A 1 , A 2A , and A 3 receptors (ARs) and extracellular signal‐regulated kinase 1/2 (ERK1/2) play a major role in myocardium protection from ischaemic injury. In this study, we have characterized the adenosine receptor subtypes involved in ERK1/2 activation in newborn rat cardiomyocytes. Adenosine (nonselective agonist), CPA (A 1 ), CGS 21680 (A 2A ) or Cl‐IB‐MECA (A 3 ), all increased ERK1/2 phosphorylation in a time‐ and dose‐dependent manner. The combined maximal response of the selective agonists was similar to adenosine alone. Theophylline (nonselective antagonist) inhibited completely adenosine‐mediated ERK1/2 activation, whereas a partial inhibition was obtained with DPCPX (A 1 ), ZM 241385 (A 2A ), and MRS 1220 (A 3 ). PD 98059 (MEK1; ERK kinase inhibitor) abolished all agonist‐mediated ERK1/2 phosphorylation. Pertussis toxin (PTX, G i/o blocker) inhibited completely CPA‐ and partially adenosine‐ and Cl‐IB‐MECA‐induced ERK1/2 activation. Genistein (tyrosine kinase inhibitor) and Ro 318220 (protein kinase C, PKC inhibitor) partially reduced adenosine, CPA and Cl‐IB‐MECA responses, without any effect on CGS 21680‐induced ERK1/2 phosphorylation. H89 (protein kinase A, PKA inhibitor) abolished completely CGS 21680 and partially adenosine and Cl‐IB‐MECA responses, without any effect on CPA response. Cl‐IB‐MECA‐mediated increases in cAMP accumulation suggest that A 3 AR‐induced ERK1/2 phosphorylation involves adenylyl cyclase activation via phospholipase C (PLC) and PKC stimulation. In summary, we have shown that ERK1/2 activation by adenosine in cardiomyocytes results from an additive stimulation of A 1 , A 2A , and A 3 ARs, which involves G i/o proteins, PKC, and tyrosine kinase for A 1 and A 3 ARs, and Gs and PKA for A 2A ARs. Moreover, the A 3 AR response also involves a cAMP/PKA pathway via PKC activation.British Journal of Pharmacology (2004) 141 , 329–339. doi: 10.1038/sj.bjp.0705614

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom